Jerylle's Fight Against Neuroblastoma Cancer

Jerylle is 8 years old and is facing his 2nd relapse of Neuroblastoma, an incurable childhood cancer. 
He was first diagnosed at age 3 and he has faced each challenge head on and with a smile on his face and a resilient spirit. 
He has been surrounded by his incredible family who has fought with him each step of the way. 
In the last few months alone, Jerylle has faced more than most of us could imagine.
Jerylle is a true superhero and warrior. He has been an inspiration to me personally and countless others.

If you would like to give to Jerylle's family as they face many challenges ahead, any amount is greatly appreciated. 
If you cannot give, please share. ❤

Money raised will go towards 
Treatment
Accomadations/Travel/Food while away
Hospital Parking
Gas
Bills incurred from time off work
Any care/medications needed for Jerylle.
Any needs the family have.

Jerylle's mom Arlene, shares his story below. 

Jerylle was diagnosed in July 2014 with stage 4 neuroblastoma. He did a frontline treatment for 16 months and went into remission. He relapsed on April/17 and went into remission again in Nov/17, but continued his chemo treatment until June/18. On a routine scan at the end of August, something lite up in the MIBG scan, which was inconclusive. We repeated his scan in October and had MRI Done as well. That is when we found out about brain relapsed with spots on his hip and legs and bone marrow involvement as well.

After he went into remission the first time (Oct/16) we participated with a trial in the US called DFMO, which was supposed to help in preventing relapsed. We were on it for 18 months when we relapsed the first time.

Neuroblastoma is a childhood cancer that affects 700 kids/year in North America. It usually shows up from infant to 18 months old. Jerylle was 3.5 years old when he was diagnosed. Neuroblastoma is an incurable disease and the chance of relapse is very high. He will be undergoing a clinical trial treatment in the states once he is done radiation, which will most likely be in February. This is not funded by the Alberta government, but a financial assistance might be possible from the clinical trial.